Hyperventilation: A Possible Explanation for Long-Lasting Exercise Intolerance in Mild COVID-19 Survivors?
- PMID: 33536937
- PMCID: PMC7849606
- DOI: 10.3389/fphys.2020.614590
Hyperventilation: A Possible Explanation for Long-Lasting Exercise Intolerance in Mild COVID-19 Survivors?
Abstract
Since the outbreak of the coronavirus (COVID-19) pandemic, most attention has focused on containing transmission and addressing the surge of critically ill patients in acute care settings. As we enter the second phase of the pandemic, emphasis must evolve to post-acute care of COVID-19 survivors. Persisting cardiorespiratory symptoms have been reported at several months after the onset of the infection. Information is lacking on the pathophysiology of exercise intolerance after COVID-19. Previous outbreaks of coronaviruses have been associated with persistent dyspnea, muscle weakness, fatigue and reduced quality of life. The extent of Covid-19 sequelae remains to be evaluated, but persisting cardiorespiratory symptoms in COVID-19 survivors can be described as two distinct entities. The first type of post-Covid symptoms are directly related to organ injury in the acute phase, or the complications of treatment. The second type of persisting symptoms can affect patients even with mild initial disease presentation without evidence of organ damage. The mechanisms are still poorly qualified to date. There is a lack of correlation between initial symptom severity and residual symptoms at exertion. We report exercise hyperventilation as a major limiting factor in COVID-19 survivors. The origin of this hyperventilation may be related to an abnormality of ventilatory control, by either hyperactivity of activator systems (automatic and cortical ventilatory control, peripheral afferents, and sensory cortex) or failure of inhibitory systems (endorphins) in the aftermath of pulmonary infection. Hyperventilation-induced hypocapnia can cause a multitude of extremely disabling symptoms such as dyspnea, tachycardia, chest pain, fatigue, dizziness and syncope at exertion.
Keywords: COVID-19; SARS-CoV-2; cardiopulmonary exercise testing; dyspnea; exercise hyperventilation; hyperventilation syndrome; persisting symptoms.
Copyright © 2021 Motiejunaite, Balagny, Arnoult, Mangin, Bancal, d’Ortho and Frija-Masson.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.Lancet Respir Med. 2022 Sep;10(9):863-876. doi: 10.1016/S2213-2600(22)00126-6. Epub 2022 May 11. Lancet Respir Med. 2022. PMID: 35568052 Free PMC article.
-
Dyspnea in Post-COVID Syndrome following Mild Acute COVID-19 Infections: Potential Causes and Consequences for a Therapeutic Approach.Medicina (Kaunas). 2022 Mar 12;58(3):419. doi: 10.3390/medicina58030419. Medicina (Kaunas). 2022. PMID: 35334595 Free PMC article. Review.
-
Respiratory rehabilitation for Covid-19 related persistent dyspnoea: A one-year experience.Respir Med. 2021 Nov-Dec;189:106648. doi: 10.1016/j.rmed.2021.106648. Epub 2021 Oct 13. Respir Med. 2021. PMID: 34689061 Free PMC article.
-
[The role of the cardiopulmonary exercise test and pulmonary rehabilitation in long COVID-19].Rev Mal Respir. 2023 Sep;40(7):604-622. doi: 10.1016/j.rmr.2023.05.003. Epub 2023 Jun 23. Rev Mal Respir. 2023. PMID: 37357041 Free PMC article. Review. French.
-
A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.BMC Infect Dis. 2021 Jul 13;21(1):677. doi: 10.1186/s12879-021-06359-2. BMC Infect Dis. 2021. PMID: 34256735 Free PMC article.
Cited by
-
Persisting exercise ventilatory inefficiency in subjects recovering from COVID-19. Longitudinal data analysis 34 months post-discharge.BMC Pulm Med. 2024 May 25;24(1):258. doi: 10.1186/s12890-024-03070-1. BMC Pulm Med. 2024. PMID: 38796432 Free PMC article.
-
Long-term reduced functional capacity and quality of life in hospitalized COVID-19 patients.Front Med (Lausanne). 2024 Mar 6;10:1289454. doi: 10.3389/fmed.2023.1289454. eCollection 2023. Front Med (Lausanne). 2024. PMID: 38516229 Free PMC article.
-
The burden of persistent symptoms after COVID-19 (long COVID): a meta-analysis of controlled studies in children and adults.Virol J. 2024 Jan 11;21(1):16. doi: 10.1186/s12985-024-02284-3. Virol J. 2024. PMID: 38212781 Free PMC article.
-
Exercise ventilatory response after COVID-19: comparison between ambulatory and hospitalized patients.Am J Physiol Lung Cell Mol Physiol. 2023 Dec 1;325(6):L756-L764. doi: 10.1152/ajplung.00142.2023. Epub 2023 Oct 24. Am J Physiol Lung Cell Mol Physiol. 2023. PMID: 37874657 Free PMC article.
-
Dysfunctional breathing symptoms, functional impact and quality of life in patients with long COVID-19: a prospective case series.BMJ Open Respir Res. 2023 Jul;10(1):e001770. doi: 10.1136/bmjresp-2023-001770. BMJ Open Respir Res. 2023. PMID: 37433720 Free PMC article.
References
-
- Ahmed H., Patel K., Greenwood D., Halpin S., Lewthwaite P., Salawu A., et al. (2020). Long-term clinical outcomes in survivors of coronavirus outbreaks after hospitalization or icu admission: a systematic review and meta-analysis of follow-up studies. medRxiv [preprint] 10.1101/2020.04.16.20067975 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous